University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Publications for Norris Cancer Center Members in the Hematologic and Viral-Associated Malignancies Program

  • If you want to only view publications for one year, enter the 4 digit Year (e.g., 2001) and click Filter.
  • Authors who are Program members appear in bold.
  • Authors who are CC members from other programs are underlined.

Filter by Publication Year:From: To:

Total Number of Publications: 72
Inter Programmatic Publications: 43
Intra Programmatic Publications: 1

1: Basile LA, Gallaher TK, Shibata D, Miller JD, Douer D
Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing mice.
J Transl Med 6: 26 (2008)
PM ID: 18489769 PMC2424034
2: Kohn DB
Gene therapy for childhood immunological diseases.
Bone Marrow Transplant 41: 199-205 (2008)
PM ID: 17994122
3: Taylor JA, Vojtech L, Bahner I, Kohn DB, Laer DV, Russell DW, Richard RE
Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication.
Mol Ther 16: 46-51 (2008)
PM ID: 17955023
4: Bonde J, Wirthlin L, Kohn DB, Nolta JA
Human hematopoietic cell culture, transduction, and analyses.
Curr Protoc Hum Genet Chapter 13: Unit 13.7 (2008)
PM ID: 18428422
5: Lai CK, Jeng KS, Machida K, Cheng YS, Lai MM
Hepatitis C virus NS3/4A protein interacts with ATM, impairs DNA repair and enhances sensitivity to ionizing radiation.
Virology 370: 295-309 (2008)
PM ID: 17931678
6: Hao QL, George AA, Zhu JY, Barsky LW, Zielinska E, Wang XD, Price MA, Ge S, Crooks GM
Human intrathymic lineage commitment is marked by differential CD7 expression: identification of CD7- lympho-myeloid thymic progenitors.
Blood 111: 1318-26 (2008)
PM ID: 17959857 PMC2214748
7: Dowd CL, Sutch BT, Haworth IS, Eritja R, Marquez VE, Yang AS
Incorporation of zebularine from its 2'-deoxyribonucleoside triphosphate derivative and activity as a template-coding nucleobase.
Nucleosides Nucleotides Nucleic Acids 27: 131-45 (2008)
PM ID: 18205068
8: Abdel-Azim H, Zhu Y, Hollis RP, Wang XD, Ge S, Hao QL, Smbatyan G, Kohn DB, Rosol M, Crooks GM
Expansion of multipotent and lymphoid-committed human progenitors through intracellular dimerization of Mpl.
Blood 111: 4064-74 (2008)
PM ID: 18174381 PMC2288719
9: Rountree CB, Senadheera S, Mato JM, Crooks GM, Lu SC
Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice.
Hepatology 47: 1288-97 (2008)
PM ID: 18167064 PMC2408692 NIHMS49822
10: Singh H, Manuri PR, Olivares S, Dara N, Dawson MJ, Huls H, Hackett PB, Kohn DB, Shpall EJ, Champlin RE, Cooper LJ
Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system.
Cancer Res 68: 2961-71 (2008)
PM ID: 18413766 PMC2424272 NIHMS52003
11: Cozen W, Gill PS, Salam MT, Nieters A, Masood R, Cockburn MG, Gauderman WJ, Martínez-Maza O, Nathwani BN, Pike MC, Van Den Berg DJ, Hamilton AS, Deapen DM, Mack TM
Interleukin-2, interleukin-12, and interferon-gamma levels and risk of young adult Hodgkin lymphoma.
Blood 111: 3377-82 (2008)
PM ID: 18077789 PMC2275007
12: Heo K, Kim HJ, Choi SH, Choi J, Kim KJ, Gu J, Lieber MR, Yang AS, An W
FACT-mediated exchange of histone variant H2AX regulated by phosphorylation of H2AX and ADP-ribosylation of Spt16.
Mol Cell 30: 86-97 (2008)
PM ID: 18406329
13: Carbonaro DA, Jin X, Cotoi D, Mi T, Yu XJ, Skelton DC, Dorey F, Kellems RE, Blackburn MR, Kohn DB
Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansion.
Blood 111: 5745-54 (2008)
PM ID: 18356486 PMC2424166
14: Chu MW, Siegmund KD, Hao QL, Crooks GM, Tavaré S, Shibata D
Inferring relative numbers of human leucocyte genome replications.
Br J Haematol 141: 862-71 (2008)
PM ID: 18410448
15: Shah AJ, Epport K, Azen CG, Killen R, Wilson K, De Clerck D, Crooks GM, Kapoor N, Kohn DB, Parkman R, Weinberg KI
Progressive declines in neurocognitive function among survivors of hematopoietic stem cell transplantation for pediatric hematologic malignancies.
J Pediatr Hematol Oncol 30: 411-8 (2008)
PM ID: 18525456
16: Melchior K, Weiss JM, Zaehres H, Kim YM, Lutzko C, Roosta N, Hescheler J, Müschen M
The WNT receptor FZD7 contributes to self-renewal signaling of human embryonic stem cells.
Biol Chem 389: 897-903 (2008)
PM ID: 18681827
17: Müschen M
Highlight: self-renewal signaling in stem cells.
Biol Chem 389: 787 (2008)
PM ID: 18681824
18: Machida K, Kondo Y, Huang JY, Chen YC, Cheng KT, Keck Z, Foung S, Dubuisson J, Sung VM, Lai MM
Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein.
J Virol 82: 6711-20 (2008)
PM ID: 18417597 PMC2447061
19: Kahl CA, Cannon PM, Oldenburg J, Tarantal AF, Kohn DB
Tissue-specific restriction of cyclophilin A-independent HIV-1- and SIV-derived lentiviral vectors.
Gene Ther 15: 1079-89 (2008)
PM ID: 18385767
20: Byun HM, Choi SH, Laird PW, Trinh BN, Siddiqui MA, Marquez VE, Yang AS
2'-Deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine: a novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase 1.
Cancer Lett 266: 238-48 (2008)
PM ID: 18499340 PMC2528876 NIHMS57985
21: Ren YX, Finckenstein FG, Abdueva DA, Shahbazian V, Chung B, Weinberg KI, Triche TJ, Shimada H, Anderson MJ
Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations.
Cancer Res 68: 6587-97 (2008)
PM ID: 18701482
22: Yoo CB, Chuang JC, Byun HM, Egger G, Yang AS, Dubeau L, Long TI, Laird PW, Marquez VE, Jones PA
Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice.
Cancer Prev Res (Phila Pa) 1: 233-40 (2008)
PM ID: 19138966
23: Lai CK, Jeng KS, Machida K, Lai MM
Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A.
J Virol 82: 8838-48 (2008)
PM ID: 18562541 PMC2519648
24: Tsai AG, Lu H, Raghavan SC, Muschen M, Hsieh CL, Lieber MR
Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity.
Cell 135: 1130-42 (2008)
PM ID: 19070581 PMC2642632 [Available on 12/12/09] NIHMS84558 [Available on 12/12/09]
25: Iacobucci I, Lonetti A, Cilloni D, Messa F, Ferrari A, Zuntini R, Ferrari S, Ottaviani E, Arruga F, Paolini S, Papayannidis C, Piccaluga PP, Soverini S, Saglio G, Pane F, Baruzzi A, Vignetti M, Berton G, Vitale A, Chiaretti S, Müschen M, Foà R, Baccarani M, Martinelli G
Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method.
Haematologica 93: 1814-21 (2008)
PM ID: 18838475
26: Douer D
Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?
Best Pract Res Clin Haematol 21: 647-58 (2008)
PM ID: 19041604
27: Kondo Y, Machida K, Liu HM, Ueno Y, Kobayashi K, Wakita T, Shimosegawa T, Lai MM
Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6.
J Infect Dis 199: 726-36 (2009)
PM ID: 19199548
28: Aparicio A, North B, Barske L, Wang X, Bollati V, Weisenberger D, Yoo C, Tannir N, Horne E, Groshen S, Jones P, Yang A, Issa JP
LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors.
Epigenetics 4: 176-84 (2009)
PM ID: 19421002
29: Liu HM, Aizaki H, Choi KS, Machida K, Ou JJ, Lai MM
SYNCRIP (synaptotagmin-binding, cytoplasmic RNA-interacting protein) is a host factor involved in hepatitis C virus RNA replication.
Virology 386: 249-56 (2009)
PM ID: 19232660
30: Choi SH, Worswick SD, Byun HM, Shear T, Soussa JC, Wolff EM, Douer D, Garcia-Manero G, Liang G, Yang AS
Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer.
Int J Cancer 125: 723-9 (2009)
PM ID: 19437537
31: Trageser D, Iacobucci I, Nahar R, Duy C, von Levetzow G, Klemm L, Park EJ, Schuh W, Gruber TA, Herzog S, Kim YM, Hofmann WK, Li AX, Storlazzi CT, Jäck HM, Groffen J, Martinelli G, Heisterkamp N, Jumaa H, Müschen M
Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function.
J Exp Med 206: 1739-53 (2009)
PM ID: 19620627 PMC2722172 [Available on 02/03/10]
32: Leonard RC, Williams S, Tulpule A, Levine AM, Oliveros S
Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet).
Breast 18: 218-24 (2009)
PM ID: 19656681
33: Klemm L, Duy C, Iacobucci I, Kuchen S, von Levetzow G, Feldhahn N, Henke N, Li Z, Hoffmann TK, Kim YM, Hofmann WK, Jumaa H, Groffen J, Heisterkamp N, Martinelli G, Lieber MR, Casellas R, Müschen M
The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia.
Cancer Cell 16: 232-45 (2009)
PM ID: 19732723
34: Cozen W, Hamilton AS, Zhao P, Salam MT, Deapen DM, Nathwani BN, Weiss LM, Mack TM
A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma.
Blood 114: 4014-20 (2009)
PM ID: 19738032 PMC2774542 [Available on 11/05/10]
35: Byun HM, Siegmund KD, Pan F, Weisenberger DJ, Kanel G, Laird PW, Yang AS
Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns.
Hum Mol Genet 18: 4808-17 (2009)
PM ID: 19776032
36: Sumiyoshi T, Holt NG, Hollis RP, Ge S, Cannon PM, Crooks GM, Kohn DB
Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.
Hum Gene Ther 20: 1607-26 (2009)
PM ID: 19689196
37: Machida K, Liu JC, McNamara G, Levine A, Duan L, Lai MM
Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway.
J Virol 83: 12590-600 (2009)
PM ID: 19793824 PMC2786750 [Available on 06/01/10]
38: Nowak D, Ogawa S, Müschen M, Kato M, Kawamata N, Meixel A, Nowak V, Kim HS, Kang S, Paquette R, Chang MS, Thoenissen NH, Mossner M, Hofmann WK, Kohlmann A, Weiss T, Haferlach T, Haferlach C, Koeffler HP
SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations.
Blood 115: 1049-53 (2009)
PM ID: 19965645
39: Nahar R, Müschen M
Pre-B cell receptor signaling in acute lymphoblastic leukemia.
Cell Cycle 8: 3874-7 (2009)
PM ID: 19901533
40: Kantarjian HM, Erba HP, Claxton D, Arellano M, Lyons RM, Kovascovics T, Gabrilove J, Craig M, Douer D, Maris M, Petersdorf S, Shami PJ, Yeager AM, Eckert S, Abichandani R, Faderl S
Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.
J Clin Oncol 28: 549-55 (2010)
PM ID: 20026805
41: Wang XM, Greiner TC, Bibikova M, Pike BL, Siegmund KD, Sinha UK, Müschen M, Jaeger EB, Weisenburger DD, Chan WC, Shibata D, Fan JB, Hacia JG
Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations.
J Cell Biochem 109: 818-27 (2010)
PM ID: 20069569 PMC3122883 NIHMS305118
42: Fei F, Stoddart S, Müschen M, Kim YM, Groffen J, Heisterkamp N
Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia.
Leukemia 24: 813-20 (2010)
PM ID: 20111071 PMC3038787 NIHMS164648
43: Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, Yang AS, Jones PA, Liang G
Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer.
PLoS Genet 6: e1000917 (2010)
PM ID: 20421991 PMC2858672
44: Müschen M
Genetic relicts from the origin of ALL.
Blood 115: 3424-5 (2010)
PM ID: 20430963
45: Duy C, Yu JJ, Nahar R, Swaminathan S, Kweon SM, Polo JM, Valls E, Klemm L, Shojaee S, Cerchietti L, Schuh W, Jäck HM, Hurtz C, Ramezani-Rad P, Herzog S, Jumaa H, Koeffler HP, de Alborán IM, Melnick AM, Ye BH, Müschen M
BCL6 is critical for the development of a diverse primary B cell repertoire.
J Exp Med 207: 1209-21 (2010)
PM ID: 20498019 PMC2882829
46: Parameswaran R, Müschen M, Kim YM, Groffen J, Heisterkamp N
A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias.
Cancer Res 70: 4346-56 (2010)
PM ID: 20460528 PMC2880197 NIHMS192821
47: Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V, Crooks GM, Kohn DB, Gregory PD, Holmes MC, Cannon PM
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.
Nat Biotechnol 28: 839-47 (2010)
PM ID: 20601939 PMC3080757 NIHMS216984
48: Chen YC, Su WC, Huang JY, Chao TC, Jeng KS, Machida K, Lai MM
Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A.
J Virol 84: 7983-93 (2010)
PM ID: 20534861 PMC2916529
49: Machida K, Tsukamoto H, Liu JC, Han YP, Govindarajan S, Lai MM, Akira S, Ou JH
c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair.
Hepatology 52: 480-92 (2010)
PM ID: 20683948 PMC3107125 NIHMS295838
50: Yun JP, Behan JW, Heisterkamp N, Butturini A, Klemm L, Ji L, Groffen J, Müschen M, Mittelman SD
Diet-induced obesity accelerates acute lymphoblastic leukemia progression in two murine models.
Cancer Prev Res (Phila) 3: 1259-64 (2010)
PM ID: 20823291 PMC2955776 NIHMS227757
51: Tallman M, Douer D, Gore S, Powell BL, Ravandi F, Rowe J, Ranganathan A, Sanz MA
Treatment of patients with acute promyelocytic leukemia: a consensus statement on risk-adapted approaches to therapy.
Clin Lymphoma Myeloma Leuk 10 Suppl 3: S122-6 (2010)
PM ID: 21115429
52: Gruber TA, Chang MS, Sposto R, Müschen M
Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia.
Cancer Res 70: 7411-20 (2010)
PM ID: 20876806 PMC2948648 NIHMS228027
53: Bernstein I, Byun HM, Mohrbacher A, Douer D, Gorospe G, Hergesheimer J, Groshen S, O'Connell C, Yang AS
A phase I biological study of azacitidine (Vidaza™) to determine the optimal dose to inhibit DNA methylation.
Epigenetics 5: 750-7 (2010)
PM ID: 20861661
54: Fang C, Wang Y, Vu NT, Lin WY, Hsieh YT, Rubbi L, Phelps ME, Müschen M, Kim YM, Chatziioannou AF, Tseng HR, Graeber TG
Integrated microfluidic and imaging platform for a kinase activity radioassay to analyze minute patient cancer samples.
Cancer Res 70: 8299-308 (2010)
PM ID: 20837665
55: Lai CK, Jeng KS, Machida K, Lai MM
Hepatitis C virus egress and release depend on endosomal trafficking of core protein.
J Virol 84: 11590-8 (2010)
PM ID: 20739534 PMC2953145
56: Machida K, McNamara G, Cheng KT, Huang J, Wang CH, Comai L, Ou JH, Lai MM
Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes.
J Immunol 185: 6985-98 (2010)
PM ID: 20974981 PMC3101474 NIHMS293685
57: Liu SV, Douer D
Reply.
Acta Haematol 126: 240 (2011)
PM ID: 21952727
58: Choi SH, Heo K, Byun HM, An W, Lu W, Yang AS
Identification of preferential target sites for human DNA methyltransferases.
Nucleic Acids Res 39: 104-18 (2011)
PM ID: 20841325 PMC3017615
59: Thai M, Ting PY, McLaughlin J, Cheng D, Müschen M, Witte ON, Colicelli J
ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1.
Leukemia 25: 290-300 (2011)
PM ID: 21102429 PMC3049868
60: Stanford SM, Krishnamurthy D, Falk MD, Messina R, Debnath B, Li S, Liu T, Kazemi R, Dahl R, He Y, Yu X, Chan AC, Zhang ZY, Barrios AM, Woods VL, Neamati N, Bottini N
Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells.
J Med Chem 54: 1640-54 (2011)
PM ID: 21341673 PMC3086468 NIHMS276264
61: Duy C, Hurtz C, Shojaee S, Cerchietti L, Geng H, Swaminathan S, Klemm L, Kweon SM, Nahar R, Braig M, Park E, Kim YM, Hofmann WK, Herzog S, Jumaa H, Koeffler HP, Yu JJ, Heisterkamp N, Graeber TG, Wu H, Ye BH, Melnick A, Müschen M
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition.
Nature 473: 384-8 (2011)
PM ID: 21593872 PMC3597744 NIHMS268753
62: Park E, Gang EJ, Hsieh YT, Schaefer P, Chae S, Klemm L, Huantes S, Loh M, Conway EM, Kang ES, Hoe Koo H, Hofmann WK, Heisterkamp N, Pelus L, Keerthivasan G, Crispino J, Kahn M, Müschen M, Kim YM
Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia.
Blood 118: 2191-9 (2011)
PM ID: 21715311 PMC3162353
63: Jiang XX, Nguyen Q, Chou Y, Wang T, Nandakumar V, Yates P, Jones L, Wang L, Won H, Lee HR, Jung JU, Müschen M, Huang XF, Chen SY
Control of B cell development by the histone H2A deubiquitinase MYSM1.
Immunity 35: 883-96 (2011)
PM ID: 22169041
64: Liu HM, Aizaki H, Machida K, Ou JH, Lai MM
Hepatitis C virus translation preferentially depends on active RNA replication.
PLoS One 7: e43600 (2012)
PM ID: 22937067 PMC3427374
65: Cozen W, Li D, Best T, Van Den Berg DJ, Gourraud PA, Cortessis VK, Skol AD, Mack TM, Glaser SL, Weiss LM, Nathwani BN, Bhatia S, Schumacher FR, Edlund CK, Hwang AE, Slager SL, Fredericksen ZS, Strong LC, Habermann TM, Link BK, Cerhan JR, Robison LL, Conti DV, Onel K
A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32.
Blood 119: 469-75 (2012)
PM ID: 22086417 PMC3257012
66: Levine AM, Noy A, Lee JY, Tam W, Ramos JC, Henry DH, Parekh S, Reid EG, Mitsuyasu R, Cooley T, Dezube BJ, Ratner L, Cesarman E, Tulpule A
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047.
J Clin Oncol 31: 58-64 (2013)
PM ID: 23169503 PMC3530691 [Available on 01/01/14]
67: Cui X, Lu Z, Kurosawa A, Klemm L, Bagshaw AT, Tsai AG, Gemmell N, Müschen M, Adachi N, Hsieh CL, Lieber MR
Both CpG methylation and activation-induced deaminase are required for the fragility of the human bcl-2 major breakpoint region: implications for the timing of the breaks in the t(14;18) translocation.
Mol Cell Biol 33: 947-57 (2013)
PM ID: 23263985 PMC3623081
68: Hsieh YT, Gang EJ, Geng H, Park E, Huantes S, Chudziak D, Dauber K, Schaefer P, Scharman C, Shimada H, Shojaee S, Klemm L, Parameswaran R, Loh M, Kang ES, Koo HH, Hofmann WK, Andrade J, Crooks GM, Willman CL, Müschen M, Papayannopoulou T, Heisterkamp N, Bönig H, Kim YM
Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.
Blood 121: 1814-8 (2013)
PM ID: 23319569 PMC3591800 [Available on 03/07/14]
69: Parameswaran R, Lim M, Arutyunyan A, Abdel-Azim H, Hurtz C, Lau K, Müschen M, Yu RK, von Itzstein M, Heisterkamp N, Groffen J
O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia.
J Exp Med 210: 805-19 (2013)
PM ID: 23478187 PMC3620349 [Available on 10/08/13]
70: Mbulaiteye SM, Pullarkat ST, Nathwani BN, Weiss LM, Nagesh Rao , Emmanuel B, Lynch CF, Hernandez B, Neppalli V, Hawes D, Cockburn MG, Kim A, Williams M, Altekruse S, Bhatia K, Goodman MT, Cozen W
Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009.
APMIS : (2013)
PM ID: 23607450 PMC3723754
71: Parekh C, Crooks GM
Critical differences in hematopoiesis and lymphoid development between humans and mice.
J Clin Immunol 33: 711-5 (2013)
PM ID: 23274800 PMC3633618 [Available on 05/01/14] NIHMS432026 [Available on 05/01/14]
72: Gang EJ, Hsieh YT, Pham J, Zhao Y, Nguyen C, Huantes S, Park E, Naing K, Klemm L, Swaminathan S, Conway EM, Pelus LM, Crispino J, Mullighan CG, McMillan M, Müschen M, Kahn M, Kim YM
Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.
Oncogene : (2013)
PM ID: 23728349